Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Blood

Volumn 117, Issue 5, 2011, Pages 1595-1604

  Rinaldi, Andrea ^a   Mian, Michael ^a,b   Chigrinova, Ekaterina ^a   Arcaini, Luca ^c   Bhagat, Govind ^d   Novak, Urban ^d   Rancoita, Paola M V ^a,e   De Campos, Cassio P ^a,e   Forconi, Francesco ^f   Gascoyne, Randy D ^g   Facchetti, Fabio ^h   Ponzoni, Maurilio ⁱ   Govi, Silvia ⁱ   Ferreri, Andrés J M ⁱ   Mollejo, Manuela ^j   Piris, Miguel A ^j   Baldini, Luca ^k   Soulier, Jean ^l   Thieblemont, Catherine ^l   Canzonieri, Vincenzo ^m   Gattei, Valter ^m   Marasca, Roberto ⁿ   Franceschetti, Silvia ^o   Gaidano, Gianluca ^o   Tucci, Alessandra ^h   Uccella, Silvia ^p   Tibiletti, Maria Grazia ^p   Dirnhofer, Stephan ^q   Tripodo, Claudio ^r   Doglioni, Claudio ^g   Favera, Riccardo Dalla ^d   Cavalli, Franco ^a   Zucca, Emanuele ^a   Kwee, Ivo ^a   Bertoni, Francesco ^a   more..

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b Division of Hematology   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e DALLE MOLLE INSTITUTE FOR ARTIFICIAL INTELLIGENCE IDSIA   (Switzerland)

^f UNIVERSITY OF SIENA   (Italy)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j Centro Nacional de Investigaciones Oncológicas   (Spain)

^k UNIVERSITY OF MILAN   (Italy)

^l SAINT LOUIS HOSPITAL   (France)

^m CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

ⁿ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^o UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^p UNIVERSITY OF INSUBRIA   (Italy)

^q UNIVERSITY OF BASEL   (Switzerland)

^r UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 18P; CHROMOSOME 3P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA FINGERPRINTING; FEMALE; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79551650559     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-264275     Document Type: Article

References (50)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361-1392. (Pubitemid 24273002)
2. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
3. Scandurra M, Mian M, Greiner TC, et al. Genomic lesions associated with a different clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP. Br J Haematol. 2010;151(3):221-231.
4. Rancoita PMV, Hutter M, Bertoni F, Kwee I. Bayesian DNA copy number analysis. BMC Bioinformatics. 2009;10(1):10.
5. Beroukhim R, Lin M, Park Y, et al. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol. 2006;2(5):e41.
6. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008;105(36):13520-13525.
7. Karolchik D, Kuhn RM, Baertsch R, et al. The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res. 2008;36(Database issue): D773-D779.
8. Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature. 1999;401(6755):788-791. (Pubitemid 129515838)
9. Vakiani E, Basso K, Klein U, et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol. 2008;26(4):199-211.
10. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med. 2010;362(10):875-885.
11. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4):e15.
12. Alter O, Golub GH. Integrative analysis of genome-scale data by using pseudoinverse projection predicts novel correlation between DNA replication and RNA transcription. Proc Natl Acad Sci U S A. 2004;101(47):16577-16582. (Pubitemid 39557755)
13. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
14. Harrell FE. Regression Modeling Strategies. Berlin, Germany: Springer-Verlag; 2001.
15. R Development Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
16. Arcaini L, Lazzarino M, Colombo N, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006;107(12):4643-4649.
17. Forconi F, Rinaldi A, Kwee I, et al. Genome-wide DNA profiling identifies an unstable profile with recurrent imbalances predicting outcome in chronic lymphocytic leukemia with 17p deletion. Br J Haematol. 2008;143(4):532-536.
18. Mollejo M, Camacho FI, Algara P, Ruiz-Ballesteros E, Garcia JF, Piris MA. Nodal and splenic marginal zone B cell lymphomas. Hematol Oncol. 2005;23(3):108-118. (Pubitemid 43061888)
19. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 2002;99(4):1299-1304.
20. Sole F, Salido M, Espinet B, et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica. 2001;86(1):71-77.
21. Gruszka-Westwood AM, Hamoudi R, Osborne L, Matutes E, Catovsky D. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer. 2003;36(1):57-69. (Pubitemid 36077382)
22. Ruiz-Ballesteros E, Mollejo M, Mateo M, Algara P, Martinez P, Piris MA. MicroRNA losses in the frequently deleted region of 7q in SMZLs. Leukemia. 2007;21(12):2547-2549. (Pubitemid 350148903)
23. Vega F, Cho-Vega JH, Lennon PA, et al. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes. Br J Haematol. 2008;142(2):216-226.
24. Novara F, Arcaini L, Merli M, et al. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma. Hum Pathol. 2009;40(11):1628-1637.
25. Salido M, Baro C, Oscier D, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010;116(9):1479-1488.
26. Novak U, Rinaldi A, Kwee I, et al. The NF-KB negative regulator TNFAIP3 (A20) is commonly inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas. Blood. 2009;113(20):4918-4921.
27. Compagno M, Lim WK, Grunn A, et al. Mutations at multiple genes cause deregulation of the NF-kB pathway in diffuse large B-cell lymphoma. Nature. 2009;459:717-721.
28. Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712-716.
29. Chanudet E, Ye H, Ferry J, et al. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol. 2009;217(3):420-430.
30. Braggio E, Keats JJ, Leleu X, et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res. 2009;69(8):3579-3588.
31. O'Shea D, O'Riain C, Gupta M, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood. 2009;113(10):2298-2301.
32. Rinaldi A, Capello D, Scandurra M, et al. SNP-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma. Br J Haematol. 2010;149(7):569-577.
33. Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE. 2009;4(4):e5360.
34. Skibola CF, Bracci PM, Halperin E, et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet. 2009;41(8):873-875.
35. Drenou B, Tilanus M, Semana G, et al. Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas. Br J Haematol. 2004;127(1):40-49.
36. Wong N, Lam WC, Lai PB, Pang E, Lau WY, Johnson PJ. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol. 2001;159(2):465-471. (Pubitemid 32751077)
37. Klein A, Zang KD, Steudel WI, Urbschat S. Different mechanisms of mitotic instability in cancer cell lines. Int J Oncol. 2006;29(6):1389-1396.
38. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. t(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19(4):652-658.
39. Chng WJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma identifies new biological insights with potential diagnostic and therapeutic applications. Blood. 2009;113(3):635-645.
40. Deutsch AJ, Aigelsreiter A, Steinbauer E, et al. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol. 2008;215(4):431-444.
41. Salaverria I, Zettl A, Bea S, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol. 2007;25(10):1216-1222.
42. Chacon JI, Mollejo M, Munoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100(5):1648-1654.
43. Baldini L, Guffanti A, Cro L, et al. Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol. 1997;99(2):375-378. (Pubitemid 27497571)
44. Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 2001;97(11):3552-3558.
45. Young KH, Weisenburger DD, Dave BJ, et al. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood. 2007;110(13):4396-4405.
46. Rubio-Moscardo F, Blesa D, Mestre C, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood. 2005;106(9):3214-3222.
47. Hartmann EM, Campo E, Wright G, et al. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood. 2010;116(6):953-961.
48. Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900-909.
49. Conconi A, Bertoni F, Pedrinis E, et al. Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood. 2001;98(3):781-786.
50. Ferreira BI, Garcia JF, Suela J, et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica. 2008;93(5):670-679.